This is the current revision of this page, as edited by Boghog (talk | contribs) at 11:14, 11 January 2025 (templated cites). The present address (URL) is a permanent link to this version.
Revision as of 11:14, 11 January 2025 by Boghog (talk | contribs) (templated cites)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)Pharmaceutical compound
Identifiers | |
---|---|
IUPAC name
| |
CAS Number | |
PubChem CID | |
Chemical and physical data | |
Formula | C21H27N3O2 |
Molar mass | 353.466 g·mol |
InChI
|
12-Methoxy-LSD, is an analogue of LSD. It is not a hallucinogen in animal studies, but is a potent compound with an LD50 of only 0.1mg/kg in rabbits. Presumably it acts as an agonist at serotonin and dopamine receptors, as with LSD and other related lysergamides, but its pharmacology has not been studied with modern techniques.
See also
References
- Taeschler M (1967). "Neuro-Psychopharmacology.". In Brill H, Cole JO, Deniker P, Hippius H, Bradley PB (eds.). Proceedings of the Fifth International Congress of the Collegium Internationale Neuro-Psychopharmacologicum. Washington, D.C. March, 1966. Amsterdam: Excerpta Medica Foundation. pp. 393–397.
- Usdin E, Efron DH (1972). Psychotropic Drugs and Related Compounds. National Institute of Mental Health. p. 100. ASIN B002X3CDIY.